作者:
Martin,Stork [1]
;
Ivan,Spicka [2]
;
Jakub,Radocha [3]
;
Jiri,Minarik [4]
;
Tomas,Jelinek [5]
;
Alexandra,Jungova [6]
;
Petr,Pavlicek [7]
;
Lenka,Pospisilova [8]
;
Frantisek,Sedlak [2]
;
Jan,Straub [2]
;
Tomas,Pika [4]
;
Zdenka,Knechtova [1]
;
Anna,Fidrichova [1]
;
Ivanna,Boichuk [1]
;
Sabina,Sevcikova [9]
;
Vladimir,Maisnar [3]
;
Roman,Hajek [5]
;
Ludek,Pour [10]
作者单位:
Department of Internal Medicine, Hematology and Oncology, Faculty of Medicine, University Hospital Brno, Masaryk University, Brno, Czech Republic.
[1]
1st Medical Department - Clinical Department of Hematology of the First Faculty of Medicine, General Teaching Hospital Charles University, Prague, Czech Republic.
[2]
4th Department of Medicine - Hematology, Faculty of Medicine, Charles University Hospital, Hradec Kralove, Czech Republic.
[3]
Department of Hemato-Oncology, Faculty of Medicine and Dentistry, University Hospital Olomouc, Palacky University Olomouc, Olomouc, Czech Republic.
[4]
Department of Hematooncology, Faculty of Medicine, University Hospital Ostrava, University of Ostrava, Ostrava, Czech Republic.
[5]
Hematology and Oncology Department, Charles University Hospital, Pilsen, Czech Republic.
[6]
Department of Internal Medicine and Hematology, University Hospital Kralovske Vinohrady, Prague, Czech Republic.
[7]
Institute of Biostatistics and Analyses, Ltd., Brno, Czech Republic.
[8]
Babak Myeloma Group, Department of Pathophysiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.
[9]
Department of Internal Medicine, Hematology and Oncology, Faculty of Medicine, University Hospital Brno, Masaryk University, Brno, Czech Republic. Pour.ludek@fnbrno.cz.
[10]
Babak Myeloma Group, Department of Pathophysiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic. Pour.ludek@fnbrno.cz.
[11]
DOI
10.1007/s00277-023-05188-4
PMID
37088816
发布时间
2023-05-15